(Q44398339)

2 December 2017

title

Growth in children with chronic renal failure on intermittent versus daily calcitriol (English)

1 reference

2 December 2017

2

Gianluigi Ardissino

1 reference

2 December 2017

3

Sara Testa

1 reference

2 December 2017

4

Aldo Claris-Appiani

1 reference

2 December 2017

Claus Peter Schmitt

1

1 reference

2 December 2017

Otto Mehls

series ordinal

5

1 reference

2 December 2017

language of work or name

1 reference

8 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

18

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

440-444

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-003-1091-7

2 December 2017

exact match

0 references

cites work

Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD

1 reference

12 December 2020

Kinetics of serum 1,84 iPTH after high dose of calcitriol in uremic patients

1 reference

12 December 2020

Risk of adynamic bone disease in dialyzed patients

1 reference

12 December 2020

Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients

1 reference

12 December 2020

Daily but not pulse calcitriol therapy improves growth in experimental uremia

1 reference

12 December 2020

Calcitriol pulse therapy in patients with end-stage renal failure.

1 reference

12 December 2020

Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure

1 reference

12 December 2020

Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner

1 reference

12 December 2020

Parathyroid hormone prevents 1,25 (OH)2D3 induced down-regulation of the vitamin D receptor in growth plate chondrocytes in vitro

1 reference

12 December 2020

Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats

1 reference

12 December 2020

Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid

1 reference

12 December 2020

Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogs.

1 reference

12 December 2020

Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism?

1 reference

12 December 2020

1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia

1 reference

12 December 2020

Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial.

1 reference

12 December 2020

Skeletal growth in experimental uremia.

1 reference

12 December 2020

Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism.

1 reference

12 December 2020

Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure

1 reference

12 December 2020

Effect of vitamin D on growth cartilage cell proliferation in vitro

1 reference

12 December 2020

Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein

1 reference

12 December 2020

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

12 December 2020

Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD

1 reference

12 December 2020

Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration

1 reference

12 December 2020

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

12 December 2020

Intramuscular calcitriol for uraemic children with severe hyperparathyroidism and hypercalcaemia

1 reference

12 December 2020

Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure

1 reference

12 December 2020

Inhibition of growth by calcitriol in a proximal tubular cell line (OK).

1 reference

12 December 2020

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

12 December 2020

Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure

1 reference

12 December 2020

10.1007/S00467-003-1091-7

Identifiers

DOI

0 references

1 reference